![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 26, 2006 11:08:52 AM
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B7C4BA075%2D75F8%2D42C8%2D8313%2D657C27CA529...
Biogenerics Limited Reports on Business State of Affairs
PrintE-mailDisable live quotesRSSDigg itDel.icio.usLast Update: 11:05 AM ET Jul 26, 2006
TYLER, Texas, Jul 26, 2006 (PRIMEZONE via COMTEX) -- Biogenerics Limited (Pink Sheets:BIGN) Board of Directors today announced that the LOI that was the subject of its May 25, 2006, Press Release has had its closing date extended due to the recent illness of James Lancaster, CEO of the Company.
The Board reports that the due diligence period under the LOI has been extended. The proposed closing is to occur on or before August 31, 2006. The Company's number one business priority is the completion of these transactions.
Biogenerics further reported that its CEO, James Lancaster, was taken ill on July 4, 2006, and underwent surgery on July 14th, with the results of the surgery being favorable. At this time, Mr. Lancaster is working from his personal residence while he completes his recovery period. It is expected he will to return to full time duty during the week of August 15th. The Board is very thankful for the recovery to health that James is experiencing and welcomes him back to full duties as quickly as possible.
James Lancaster commented, "While my personal health problem could not have come at a worst time, it is something that has happened. The condition has been rectified and I am feeling stronger each day. I have been able to work on the Company's business from home with the support of my very qualified staff. Together we were able to negotiate an extension on our projects."
The Company will announce the results of its negotiations regarding these projects as pertinent facts become available.
In the July 20, 2006, Press Release BIGN clarifies that the (N-CO2) technology has been added and will be utilized along with the hydro-slotting process in the Company's well recovery endeavors
Website: http:/www.bignltd.com
About Biogenerics Limited
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM